Related Experiment Video
Updated: Jun 19, 2026
08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
A comprehensive perspective on patient adherence to topical glaucoma therapy
1Department of Ophthalmology and Visual Science, Yale University School of Medicine, Yale Eye Center, New Haven, Connecticut 06510, USA. james.tsai@yale.edu
Ophthalmology
|October 20, 2009
Summary
Identifying risk factors for poor adherence to glaucoma medications is crucial. Nonadherence can lead to irreversible vision loss and optic nerve damage, underscoring the need for patient-centered care strategies.
Area of Science:
- Ophthalmology
- Public Health
- Patient Adherence Research
Background:
- Glaucoma medication adherence is critical for preventing vision loss.
- Numerous factors can impede patients' ability to adhere to prescribed topical glaucoma medication regimens.
- Understanding these barriers is essential for effective disease management.
Purpose of the Study:
- To identify and summarize the risk factors associated with poor adherence or nonadherence to topical glaucoma medication.
- To provide a comprehensive overview of the literature on glaucoma medication adherence barriers.
Main Methods:
- A systematic literature search was conducted using keywords related to glaucoma, adherence, compliance, and risk.
- Studies were limited to English language publications focused on care within the United States.
- Publications from reputable ophthalmology journals were reviewed and synthesized.
Main Results:
- A wide range of adherence barriers exist, including medication regimen complexity, patient-specific factors, provider-related issues, and environmental influences.
- While common in the elderly, advanced age itself is not a consistent predictor of nonadherence.
- Factors like medication cost, insurance status, disease severity, and doctor-patient communication significantly impact adherence.
- Poor medication adherence correlates with reduced adherence to follow-up appointments.
Conclusions:
- Four primary categories of adherence barriers have been identified: medication regimen, patient, provider, and situational/environmental factors.
- Addressing these barriers requires a personalized, patient-centered approach to improve glaucoma management.
- Effective strategies are needed to mitigate risks associated with poor adherence, preventing visual impairment.
Related Concept Videos
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...